These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ. Put K, Avau A, Brisse E, Mitera T, Put S, Proost P, Bader-Meunier B, Westhovens R, Van den Eynde BJ, Orabona C, Fallarino F, De Somer L, Tousseyn T, Quartier P, Wouters C, Matthys P. Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156 [Abstract] [Full Text] [Related]
4. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Vastert SJ, van Wijk R, D'Urbano LE, de Vooght KM, de Jager W, Ravelli A, Magni-Manzoni S, Insalaco A, Cortis E, van Solinge WW, Prakken BJ, Wulffraat NM, de Benedetti F, Kuis W. Rheumatology (Oxford); 2010 Mar; 49(3):441-9. PubMed ID: 20019066 [Abstract] [Full Text] [Related]
11. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. Lotito AP, Campa A, Silva CA, Kiss MH, Mello SB. J Rheumatol; 2007 Apr; 34(4):823-30. PubMed ID: 17343316 [Abstract] [Full Text] [Related]
13. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, Roth J. Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102 [Abstract] [Full Text] [Related]
14. Macrophage activation syndrome in juvenile idiopathic arthritis. Cortis E, Insalaco A. Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165 [Abstract] [Full Text] [Related]
15. Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis. Unal S, Balta G, Okur H, Aytac S, Cetin M, Gumruk F, Ozen S, Gurgey A. J Pediatr Hematol Oncol; 2013 Jul; 35(5):e205-8. PubMed ID: 23274377 [Abstract] [Full Text] [Related]
16. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. Davì S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, Cron RQ, Ravelli A, MAS Study Group. J Rheumatol; 2011 Apr; 38(4):764-8. PubMed ID: 21285158 [Abstract] [Full Text] [Related]
18. Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases. Hiejima E, Komatsu H, Takeda Y, Sogo T, Inui A, Okafuji I, Nishikomori R, Nakahata T, Fujisawa T. J Paediatr Child Health; 2012 Mar; 48(3):E122-5. PubMed ID: 22050445 [Abstract] [Full Text] [Related]
19. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Shimizu M, Nakagishi Y, Yachie A. Cytokine; 2013 Feb; 61(2):345-8. PubMed ID: 23276493 [Abstract] [Full Text] [Related]